TY - JOUR
T1 - IL-15 Priming Alters IFN-g Regulation in Murine NK Cells
AU - Cimpean, Maria
AU - Keppel, Molly P.
AU - Gainullina, Anastasiia
AU - Fan, Changxu
AU - Sohn, Hyogon
AU - Schedler, Nathan C.
AU - Swain, Amanda
AU - Kolicheski, Ana
AU - Shapiro, Hannah
AU - Young, Howard A.
AU - Wang, Ting
AU - Artyomov, Maxim N.
AU - Cooper, Megan A.
N1 - Publisher Copyright:
© 2023 American Association of Immunologists. All rights reserved.
PY - 2023/11/15
Y1 - 2023/11/15
N2 - NK effector functions can be triggered by inflammatory cytokines and engagement of activating receptors. NK cell production of IFN-g, an important immunoregulatory cytokine, exhibits activation-specific IFN-g regulation. Resting murine NK cells exhibit activation-specific metabolic requirements for IFN-g production, which are reversed for activating receptor-mediated stimulation following IL-15 priming. Although both cytokine and activating receptor stimulation leads to similar IFN-g protein production, only cytokine stimulation upregulates Ifng transcript, suggesting that protein production is translationally regulated after receptor stimulation. Based on these differences in IFN-g regulation, we hypothesized that ex vivo IL-15 priming of murine NK cells allows a switch to IFN-g transcription upon activating receptor engagement. Transcriptional analysis of primed NK cells compared with naive cells or cells cultured with low-dose IL-15 demonstrated that primed cells strongly upregulated Ifng transcript following activating receptor stimulation. This was not due to chromatin accessibility changes in the Ifng locus or changes in ITAM signaling, but was associated with a distinct transcriptional signature induced by ITAM stimulation of primed compared with naive NK cells. Transcriptional analyses identified a common signature of c-Myc (Myc) targets associated with Ifng transcription. Although Myc marked NK cells capable of Ifng transcription, Myc itself was not required for Ifng transcription using a genetic model of Myc deletion. This work highlights altered regulatory networks in IL-15-primed cells, resulting in distinct gene expression patterns and IFN-g regulation in response to activating receptor stimulation. The Journal of Immunology, 2023, 211: 1481-1493.
AB - NK effector functions can be triggered by inflammatory cytokines and engagement of activating receptors. NK cell production of IFN-g, an important immunoregulatory cytokine, exhibits activation-specific IFN-g regulation. Resting murine NK cells exhibit activation-specific metabolic requirements for IFN-g production, which are reversed for activating receptor-mediated stimulation following IL-15 priming. Although both cytokine and activating receptor stimulation leads to similar IFN-g protein production, only cytokine stimulation upregulates Ifng transcript, suggesting that protein production is translationally regulated after receptor stimulation. Based on these differences in IFN-g regulation, we hypothesized that ex vivo IL-15 priming of murine NK cells allows a switch to IFN-g transcription upon activating receptor engagement. Transcriptional analysis of primed NK cells compared with naive cells or cells cultured with low-dose IL-15 demonstrated that primed cells strongly upregulated Ifng transcript following activating receptor stimulation. This was not due to chromatin accessibility changes in the Ifng locus or changes in ITAM signaling, but was associated with a distinct transcriptional signature induced by ITAM stimulation of primed compared with naive NK cells. Transcriptional analyses identified a common signature of c-Myc (Myc) targets associated with Ifng transcription. Although Myc marked NK cells capable of Ifng transcription, Myc itself was not required for Ifng transcription using a genetic model of Myc deletion. This work highlights altered regulatory networks in IL-15-primed cells, resulting in distinct gene expression patterns and IFN-g regulation in response to activating receptor stimulation. The Journal of Immunology, 2023, 211: 1481-1493.
UR - http://www.scopus.com/inward/record.url?scp=85176495528&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.2300283
DO - 10.4049/jimmunol.2300283
M3 - Article
C2 - 37747317
AN - SCOPUS:85176495528
SN - 0022-1767
VL - 211
SP - 1481
EP - 1493
JO - Journal of Immunology
JF - Journal of Immunology
IS - 10
ER -